- Home
- GERN vs YY Comparison
GERN vs YY Comparison
Compare GERN & YY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- YY
- Stock Information
- Founded
- GERN 1990
- YY 2005
- Country
- GERN United States
- YY Singapore
- Employees
- GERN N/A
- YY N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- YY EDP Services
- Sector
- GERN Health Care
- YY Technology
- Exchange
- GERN Nasdaq
- YY Nasdaq
- Market Cap
- GERN 2.5B
- YY 2.2B
- IPO Year
- GERN 1996
- YY 2012
- Fundamental
- Price
- GERN $2.89
- YY $42.94
- Analyst Decision
- GERN Strong Buy
- YY Hold
- Analyst Count
- GERN 10
- YY 3
- Target Price
- GERN $7.15
- YY $35.00
- AVG Volume (30 Days)
- GERN 14.8M
- YY 664.0K
- Earning Date
- GERN 02-26-2025
- YY 11-26-2024
- Dividend Yield
- GERN N/A
- YY 1.86%
- EPS Growth
- GERN N/A
- YY N/A
- EPS
- GERN N/A
- YY 3.11
- Revenue
- GERN $29,480,000.00
- YY $2,258,181,000.00
- Revenue This Year
- GERN $31,478.06
- YY $0.76
- Revenue Next Year
- GERN $290.89
- YY $1.88
- P/E Ratio
- GERN N/A
- YY $13.79
- Revenue Growth
- GERN 9199.68
- YY N/A
- 52 Week Low
- GERN $1.64
- YY $27.88
- 52 Week High
- GERN $5.34
- YY $43.21
- Technical
- Relative Strength Index (RSI)
- GERN 25.84
- YY 65.05
- Support Level
- GERN $2.80
- YY $37.61
- Resistance Level
- GERN $3.68
- YY $41.04
- Average True Range (ATR)
- GERN 0.18
- YY 1.47
- MACD
- GERN -0.04
- YY 0.16
- Stochastic Oscillator
- GERN 10.23
- YY 95.26
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About YY JOYY Inc.
JOYY Inc is a global technology company offering comprehensive innovation capabilities. The company enables users to interact with others in real time. The group is actively exploring and expanding its global commerce Software-as-a-Service and solutions business. JOYY emphasizes technological innovation and is recognized in the industry for its significant number of patent applications and licenses.